This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Christoph Esslinger, Ph.D.
CSO at Memo Therapeutics


Christoph Esslinger is CSO and founder of Memo Therapeutics AG, an ETH Zurich spin off active in antibody technology development and discovery of therapeutic antibodies. Dr. Esslinger pioneered strategies for the discovery of human-derived antibodies and is a co-inventor of Aducanumab and other human-derived antibodies.

Agenda Sessions

  • Human-derived Antiviral Antibodies - Accelerating Antibody Discovery Timelines

    On Demand
  • Novel Non-cancer Targets for Therapeutic Antibodies